Taken together, our results support the conclusion that NRF2 activation by G. cambogia and HCA contributed to the antioxidant effect also affects NAFLD progression through hepatic steatosis and apoptosis inhibition (Figure 6). The gene discussed is NFE2L2; the disease is metabolic dysfunction-associated steatotic liver disease.